Chronicity and Its Relationship with Genotype and Mutant in Countries Where It Is Endemic High Prevalence of Hepatitis B Virus Pre-S

10.1128/JCM.41.12.5449-5455.2003. 2003, 41(12):5449. DOI: J. Clin. Microbiol. Taltavull, Tetsutaro Sata and Kenji Abe Zhao-Hua Zhong, Andrei V. Smirnov, Teresa Casanovas Pairoj Luengrojanakul, Pradeep Krishna Shrestha, Tran Thien-Tuan Huy, Hiroshi Ushijima, Khin Maung Win, Chronicity and Its Relationship with Genotype and Mutant in Countries Where It Is Endemic High Prevalence of Hepatitis B Virus Pre-S

[1]  C. Oon,et al.  Pre-S Deletion Mutants Co-Exist with Wild-Type Virus at Low Viral Replication Stage in Singapore Chronic Hepatitis B Virus Carriers , 2002, Current Microbiology.

[2]  W. Gerlich,et al.  Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. , 2002, Virology.

[3]  M. Lappalainen,et al.  Real‐time PCR for detection and quantitation of hepatitis B virus DNA , 2001, Journal of medical virology.

[4]  H. Lei,et al.  Prevalence and significance of hepatitis B virus (HBV) pre‐S mutants in serum and liver at different replicative stages of chronic HBV infection , 2001, Hepatology.

[5]  T. Okanoue,et al.  A case‐control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C , 2001, Hepatology.

[6]  S. Hayashi,et al.  Rapid and Specific Genotyping System for Hepatitis B Virus Corresponding to Six Major Genotypes by PCR Using Type-Specific Primers , 2001, Journal of Clinical Microbiology.

[7]  H. Lei,et al.  Identification of a pre‐S2 mutant in hepatocytes expressing a novel marginal pattern of surface antigen in advanced diseases of chronic hepatitis B virus infection , 2000, Journal of gastroenterology and hepatology.

[8]  K. Fukuchi,et al.  [Hepatitis B virus gene mutations in the sera of three patients with coexisting hepatitis B surface antigen and anti-surface antibody]. , 2000, Rinsho byori. The Japanese journal of clinical pathology.

[9]  Yuan Wang,et al.  Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen , 1999, Journal of Gastroenterology.

[10]  M. Manns,et al.  The Pre‐S region determines the intracellular localization and appearance of hepatitis B virus , 1999, Hepatology.

[11]  J. Wands,et al.  Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective , 1998, Hepatology.

[12]  F. Chisari,et al.  Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis. , 1997, Cancer research.

[13]  J. Wands,et al.  The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted , 1997, Journal of virology.

[14]  G. Raimondo,et al.  PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection. , 1995, Virology.

[15]  L. Mimms,et al.  Hepatitis B virus escape mutants: “pushing the envelope” of chronic hepatitis B virus infection , 1995, Hepatology.

[16]  H. Okamoto,et al.  Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen , 1994, Journal of virology.

[17]  J. Wands,et al.  Properties of hepatitis B virus pre-S1 deletion mutants. , 1994, Virology.

[18]  H. Will,et al.  Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. , 1992, Virology.

[19]  G. Gerken,et al.  Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to Pre‐S‐ and S‐encoded viral surface antigens , 1991, Hepatology.

[20]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[21]  S. Kent,et al.  Production of antibodies recognizing a hepatitis B virus (HBV) surface antigen by administration of murabutide associated to a synthetic pre-S HBV peptide conjugated to a toxoid carrier. , 1986, Biochemical and biophysical research communications.

[22]  S. Kent,et al.  Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein. , 1986, Molecular immunology.

[23]  C. Bréchot,et al.  HEPATITIS B VACCINES WITH PRE-S GENE PRODUCT , 1986, The Lancet.

[24]  A M Prince,et al.  Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing. , 1986, Vaccine.

[25]  R. Palmiter,et al.  A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. , 1985, Science.

[26]  F. Chisari,et al.  Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[27]  F. Chisari,et al.  Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. , 1985, Science.

[28]  T. Saibara,et al.  Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1. , 1998, Cancer research.

[29]  M. Manns,et al.  Hepatitis B virus mutations in the pre-S genome before and after liver transplantation. , 1996, Hepatology.

[30]  J. Sninsky,et al.  Expression of pre-S gene-encoded proteins in liver and serum during chronic hepatitis B virus infection in comparison to other markers of active virus replication. , 1987, Journal of hepatology.

[31]  A. Alberti,et al.  Antibody to the hepatitis B virus receptor for polymerized albumin in acute infection and in hepatitis B vaccine recipients. , 1986, Journal of hepatology.